Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Targeting cancer stem cells and signalling pathways through phytochemicals: A promising approach against colorectal cancer
W Liao, L Zhang, X Chen, J **ang, Q Zheng, N Chen… - Phytomedicine, 2023 - Elsevier
Abstract Background Cancer stem cells (CSCs) are strongly associated with high
tumourigenicity, chemotherapy or radiotherapy resistance, and metastasis and recurrence …
tumourigenicity, chemotherapy or radiotherapy resistance, and metastasis and recurrence …
Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response
The paradigm for macrophage characterization has evolved from the simple M1/M2
dichotomy to a more complex model that encompasses the broad spectrum of macrophage …
dichotomy to a more complex model that encompasses the broad spectrum of macrophage …
[HTML][HTML] Recent advances in hematopoietic cell kinase in cancer progression: Mechanisms and inhibitors
Q Zeng, J He, X Chen, Q Yuan, L Yin, Y Liang… - Biomedicine & …, 2024 - Elsevier
Hematopoietic cell kinase (Hck), a non-receptor tyrosine kinase belonging to the Src kinase
family, is intricately linked to the pathogenesis of numerous human diseases, with a …
family, is intricately linked to the pathogenesis of numerous human diseases, with a …
Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis
M Hashimoto, Y Kojima, T Sakamoto, Y Ozato… - …, 2024 - thelancet.com
Background Cell–cell interaction factors that facilitate the progression of adenoma to
sporadic colorectal cancer (CRC) remain unclear, thereby hindering patient survival …
sporadic colorectal cancer (CRC) remain unclear, thereby hindering patient survival …
Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages
M Zhu, L Bai, X Liu, S Peng, Y **e… - Journal for …, 2022 - pmc.ncbi.nlm.nih.gov
Background Colony-stimulating factor 1 receptor (CSF1R), a classic tyrosine kinase
receptor, has been identified as a proto-oncogene in multiple cancers. The CSF1/CSF1R …
receptor, has been identified as a proto-oncogene in multiple cancers. The CSF1/CSF1R …
Applications of human organoids in the personalized treatment for digestive diseases
Q Wang, F Guo, Y **, Y Ma - Signal Transduction and Targeted …, 2022 - nature.com
Digestive system diseases arise primarily through the interplay of genetic and environmental
influences; there is an urgent need in elucidating the pathogenic mechanisms of these …
influences; there is an urgent need in elucidating the pathogenic mechanisms of these …
Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study
P Zheng, Y Tan, Q Liu, C Wu, J Kang, S Liang, L Zhu… - Heliyon, 2024 - cell.com
Background Hematopoietic cell signal transducer (HCST) and tyrosine kinase-binding
protein (TYROBP) are triggering receptors expressed on myeloid cells 2 (TREM2), which are …
protein (TYROBP) are triggering receptors expressed on myeloid cells 2 (TREM2), which are …
Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
J Yu, X Wu, J Song, Y Zhao, H Li, M Luo… - Frontiers in …, 2022 - frontiersin.org
Immune checkpoint blockade and MAPK-targeted combined therapy is a promising regimen
for advanced melanoma patients. However, the clinical benefit from this combo regimen …
for advanced melanoma patients. However, the clinical benefit from this combo regimen …
Tumor‐infiltrating gamma delta T‐cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer
L Yu, Z Wang, Y Hu, Y Wang, N Lu… - International Journal of …, 2023 - Wiley Online Library
The γδT‐cells recognize infected or transformed cells. However, unlike αβT‐cells, γδT‐cells
are innate‐like immune cells, with no major histocompatibility complex restriction …
are innate‐like immune cells, with no major histocompatibility complex restriction …
Sodium tanshinone IIA sulfonate as a potent IDO1/TDO2 dual inhibitor enhances anti-PD1 therapy for colorectal cancer in mice
R Zhang, Y Wang, D Liu, Q Luo, P Du… - Frontiers in …, 2022 - frontiersin.org
Although the antitumor efficacy of immune checkpoint blockade (ICB) has been proved in
colorectal cancer (CRC), the results are unsatisfactory, presumably owing to the presence of …
colorectal cancer (CRC), the results are unsatisfactory, presumably owing to the presence of …